eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 27/08/2010
PIL Fortum for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/08/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change from BAN to rINN
  • Change due to user-testing of patient information
  • Change to name of manufacturer
Updated on 18/05/2004 and displayed until 27/08/2010
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
  • Company name change or merger
Updated on 10/03/2003 and displayed until 18/05/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 22/07/2002 and displayed until 10/03/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 23/05/2002 and displayed until 22/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 02/05/2002 and displayed until 23/05/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 24/11/2000 and displayed until 02/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ceftazidime pentahydrate